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Yellow gentian root extract provokes concentration- and 
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Yellow gentian (Gentiana lutea L.), a medicinal plant widely used in traditional medicine, displays multiple biological 
effects, ranging from beneficial to toxic. Since many promising applications have been reported so far, our aim was to 
evaluate its potential concentration- and time- dependent cytotoxic and genotoxic effects in vitro. To that end we exposed 
human peripheral blood mononuclear cells to 0.5, 1, and 2 mg/mL of yellow gentian root extract (YGRE) to determine 
its effects on oxidative stress parameters [pro/antioxidant balance (PAB) and lipid peroxidation], DNA damage (alkaline 
comet assay and chromosome aberrations), and cell viability (trypan blue exclusion test). Cell viability decreased with 
increasing concentrations and treatment duration. Only the lowest YGRE concentration (0.5 mg/mL) increased oxidative 
stress but produced minor DNA damage and cytotoxicity. At higher concentrations, redox parameters returned to near 
control values. The percentage of chromosome aberrations and percentage of DNA in the comet tail increased with 
increased YGRE concentration after 48 h and declined after 72 h of treatment. This points to the activation of DNA repair 
mechanism (homologous recombination), evidenced by the formation of chromosomal radial figures after 72 h of treatment 
with the highest YGRE concentration of 2 mg/mL. Our results suggest that YGRE, despite induction of cytotoxic and 
genotoxic effects, activates cell repair mechanisms that counter oxidative and DNA lesions and induce cell death in highly 
damaged cells. Therefore, observed protective effects of yellow gentian after longer exposure could be a result of activated 
repair and removal of cells with irreparable damage.
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Yellow gentian (Gentiana lutea L.) belongs to the 
Gentianaceae family, which is common in the mountainous 
regions of Europe, Southeast Asia, and North America (1). 
Virtually all plant parts (leaves, flowers, rhizomes, roots) 
or whole plants are used in traditional medicine. The root 
has been used to mitigate gastrointestinal disorders for 
thousands of years. It is also used to support gallbladder 
and liver functions and treat dyspepsia, anorexia, fever, sore 
throat, and rheumatic pain (2). It has a bitter taste due to 
the presence of triterpenoids, amarogentin and 
gentiopicroside in particular. Its extract contains many other 
bioactive compounds, such as xantones, flavonoids, and 
iridoids (1, 3), some of which exhibit beneficial anti-
inf lammatory,  an t ioxida t ive ,  rad ioprotec t ive , 
immunomodulatory, and antimicrobial effects (2, 4–7). 
Some reports suggest that the root extract has a potential 
to prevent and treat obesity, prevent insulin resistance and 
type 2 diabetes mellitus, and to mitigate cardiovascular 
complications, including atherosclerosis (8–10).
Therefore, it is hardly surprising that yellow gentian 
extract has been the subject of numerous pharmacological 
studies in recent years. However, several have reported that 
crude extract can cause oxidative and genotoxic damage, 
disturb cell proliferation, and trigger cell death (11–13). Its 
Corresponding author: Jelena Filipović Tričković, Vinča Institute of 
Nuclear Sciences – National Institute of the Republic of Serbia, University 
of Belgrade, Mike Petrovića Alasa 12–14, 11001 Belgrade, Serbia
E-mail: filipovicj@vin.bg.ac.rs, jelena.fil@hotmail.com
Valenta Šobot A, et al. Yellow gentian root extract provokes concentration- and time-dependent response in peripheral blood mononuclear cells 
Arh Hig Rada Toksikol 2020;71:320-328
321
cytotoxic effects have also been demonstrated against 
malignant cell lines, suggesting that yellow gentian extract 
has a potential for anticancer treatment (14, 15).
Taking into account multiple biological effects of yellow 
gentian, widespread traditional use and high potential for 
applications, evaluation of its cytotoxicity and genotoxicity 
are essential.
The aim of this study was to evaluate in vitro effects of 
yellow gentian root extract (YGRE) applied at different 
concentrations on redox parameters (pro/antioxidant 
balance and lipid peroxidation), DNA damage, and survival 
of human peripheral blood mononuclear cells after 48 and 
72 h of treatment.
MATERIALS AND METHODS
Yellow gentian root extract (YGRE) preparation
Yellow gentian root (serial number 03970219) was 
purchased from the Institute of Medicinal Plant Research 
“Dr Josif Pančić”, Belgrade, Serbia (CAC/RCP 1-1969, 
rev.4-2003). Before extraction, the root was ground with a 
hand grinder. In order to optimise and standardise the 
extraction technique, ground particles were imaged after 
each stage of extract preparation, namely powder, 
lyophilisate, and dissolved lyophilisate (Figure 1), with a 
field emission scanning electron microscope (FESEM) with 
energy dispersive spectroscope (EDS) (FEI SCIOS 2, 
Thermo Fisher Scientific FEI Company, Tokyo, Japan) at 
350x magnification and their size determined with 
SemAfore 5.2 software (Insinööritoimisto J.  Rimppi Oy, 
Ojakkala, Finland).
The obtained aqueous extract was placed in 25 mL 
acrylic chambers, transferred in the freezer at -18 °C and 
allowed to freeze for 24 h. Pre-frozen supernatant was then 
vacuum freeze-dried under vacuum pressure of 400 Pa for 
48 h.
Before dissolving, lyophilised powder was kept in a 
desiccator at 4 °C and then dissolved in 50 % ethanol to 
obtain the concentration of 50 mg/mL. Particle size 
measurements showed that lyophilised particle aggregates 
consisted of soluble compounds. Dissolved lyophilisate was 
filtered through a 0.2 μm pore diameter Minisart® filter 
(Sartorius, Göttingen, Germany) in order to eliminate the 
remaining non-soluble particles and sterilise the extract 
solution. The filtrate was to determine the concentration of 
secoiridoids in the extract. The final extract concentrations 
in cell cultures were 0.5, 1, and 2 mg/mL.
Ultra performance liquid chromatography (UPLC)
Chromatographic separations of YGRE constituents 
were done by ACQUITY UPLC system (Malvern 
Panalytical Ltd, Malvern, UK) with a photodiode array 
(PDA) detector and a LUNA 3u, C18(2), 3 µm, 
100 mm × 2 mm Phenomenex column as a stationary phase 
(Phenomenex, Torrance, CA, USA). All analyses were done 
under the gradient condition (Table 1), with a mobile phase 
consisting of solvent A (0.1 wt % HCOOH in water) and 
solvent B (0.1 wt % HCOOH in methanol) at a constant 
flow rate of 0.3 mL/min. Autosampler was maintained at 
4 °C. 3D chromatograms were recorded in the wavelength 
range of 210–450 nm. The run time was 6 min, and the 
injection volume 3.5 µL.
Isolation and cultivation of human peripheral blood 
mononuclear cells
Peripheral blood samples were collected in Li-heparin 
vacutainers (2 x 10 mL) from three healthy donors aged 20 
to 40 years. All subjects signed informed consent, and the 
study was approved by the Ethics Committee of the Vinča 
Institute of Nuclear Sciences – National Institute of the 
Republic of Serbia.
Peripheral blood mononuclear cells (PBMC) were 
isolated in Ficoll™ medium (Thermo Fisher Scientific, 
Waltham, MA, USA) and resuspended in RPMI 1640 
medium supplemented with 1 % penicillin–streptomycin 
and 10 % foetal bovine serum (FBS) at a concentration of 
1×106 viable cells/mL. The obtained cell cultures were then 
incubated with root extract at 37 °C for 48 and 72 h.
Trypan blue exclusion test
Trypan blue was used to evaluate cell viability as 
described elsewhere (17). Briefly, equal volumes of PBMC 
suspension and 0.4 % Trypan blue dye were mixed and 
applied to a haemocytometer (Cambridge Instruments Inc., 
Buffalo, NY, USA). Live, unstained cells were counted in 
four sets of 16 squares. Viable cell counts per mL represent 
the mean of each set, multiplied by 104 and by 2 as dye 
dilution correction factor.
Chromosome aberrations assay
To establish cell cultures, 0.5 mL of heparinised whole 
blood was added in RPMI 1640 medium supplemented with 
1 % penici l l in–streptomycin,  10 % FBS,  and 
phytohaemagglutinin and treated with YGRE to obtain final 
concentrations of 0.5, 1, and 2 mg/mL. All chemicals used 
for cell culture were purchased from Capricorn Scientific 
GmbH (Ebsdorfergrund, Germany). Harvesting was 
performed 48 and 72 h after culture initiation. Three hours 
before harvesting, colchicine (Sigma-Aldrich Co., St. Louis, 
MO, USA) was added (in the final concentration of 2.5 µg/
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Table 1 Gradient condition details used for UPLC separation.
time (min) % B
0 → 2 10 → 28
2 → 3.5 28 → 30
3.5 → 5 30 → 55
5 → 5.1 55 → 10
5.1 → 6 10 →
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solution II was made of 0.1 mL TMB/DMSO (6 mg/mL) 
and 5 mL acetate buffer (0.05 mol/L, pH 5.6).
In each well of reaction plate, 10 µL of sample/standard/
blank was mixed with 180 µL of working solution, freshly 
made from 0.5 mL of TMB cation and 5 mL TMB solution 
II that were mixed for 6 min at room temperature in the 
dark. Then, the plate was incubated for 12 min at 37 °C, in 
a dark place. The reaction was stopped by adding 40 µL of 
2 mol/L HCl to each well.
The difference between these parallel reactions was 
measured as optical density (OD) at 450 nm wavelength, 
with a reference wavelength of 570 nm on absorbance 
microplate reader Sunrise (Tecan Group Ltd, Männedorf, 
Switzerland). The PAB values were calculated from the 
standard curve that represents the percentage of hydrogen 
peroxide in the standard solution and were expressed in 
arbitrary Hamidi-Koliakos (HK) units.
Lipid peroxidation product (LPP) assay
Lipid peroxidation product (LPP) assay used in this 
study is based on the reaction of chromogen N-methyl-2-
phenylindole with products of lipid peroxidation, namely 
malondialdehyde (MDA) and 4-hydroxyalkenals (HNE) 
(22, 23).
After treatment, cells were washed and lysed in 0.9 % 
NaCl in freeze-thaw cycles. An aliquot of the samples was 
used for protein determination. The reaction mixture 
contained 140 µL of sample/standard/blank, 455 µL of 
reagent diluted in acetonitrile/methanol (3:1) to a final 
concentration of 10 mmol/L, and 105 µL of methanesulphonic 
acid containing 34 µmol/L Fe(III). It was added to 
microcentrifuge tubes, vortexed, and incubated at 45 °C for 
60 min. Samples were centrifuged at 15000xg for 10 min 
to obtain a clear supernatant.
The product of this reaction is a stabile chromophore, 
whose OD value was measured at 586 nm on the Sunrise 
absorbance microplate reader (Tecan). The values are 
presented as nmol of LPP per mg of protein using a standard 
curve of 1,1,3,3-tetramethoxypropane.
Statistical analysis
All experiments were done in duplicate and repeated 
three times. The results are presented as means ± standard 
error (SE). ANOVA test and Pearson correlation coefficient 
were used for statistical analysis. The level of significance 
was set at p<0.05. All statistical analyses were run on the 
SPSS 10 for Windows (IBM, Armonk, NY, USA).
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mL) to collect metaphase cells. Cell cultures were then 
centrifuged and treated with hypotonic solution (0.56 % 
KCl) at 37 °C for 20 min. The supernatant was removed 
and cells fixed in Carnoy’s fixative solution (3:1 methanol-
to-glacial acetic acid ratio), washed three times in fixative, 
and pipetted on clean microscopic slides. Slides were 
dehydrated with increasing concentrations of ethanol (70, 
95, and 100 %), stained with 4′,6′- diamidino-2-phenylindole 
(DAPI)-containing Vectashield solution (Vector Laboratories 
Ltd, Peterborough, UK), and analysed under a Zeiss-
Axioimager A1 microscope (Carl Zeiss, Jena, Germany), 
with the ISIS imaging software package (MetaSystems Hard 
& Software GmbH, Altlussheim, Germany). At least 200 
complete metaphase spreads per sample were analysed, 
whereas the scoring criteria included determination of 
karyotype and indicators of chromosome damage 
(chromosome breaks, dicentric and ring chromosomes, 
acentric fragments, and radial figures) (18, 19).
Alkaline comet assay
The alkaline comet assay was an adaptation of the 
method described by Singh et al. (20). Briefly, PBMC 
treated for 48 h were washed in phosphate buffer saline 
(PBS), resuspended in 1 % low melting point agarose 
(LMPA) in PBS at 37 °C, and placed on microscopic slides 
precoated with a thin layer of 1 % normal melting point 
agarose (NMPA). Slides were allowed to settle at 4 °C for 
10 min and then immersed in a lysis solution at 4 °C for 
1 h. Electrophoresis was performed at the same temperature 
and voltage of 25 V (1 V/cm, 300 mA) for 20 min. Slides 
were then washed three times in 0.4 mol/L Tris-HCl, pH 
7.5, at 4 °C, air dried, and counterstained with a DAPI-
containing Vectashield solution. At least 300 cells were 
evaluated for each slide under a Zeiss-Axioimager A2 
microscope with automated Metafer CometScan software 
(MetaSystems). The results are presented as the percentage 
of DNA in the comet tail (% DNA).
Prooxidant-antioxidant balance (PAB) assay
The assay was done as described by Alamdari et al. (21), 
with minor modifications. This method is based on two 
concomitant oxidation-reduction reactions in the same 
sample. In the first reaction, catalysed by horse radish 
p e r o x i d a s e  ( H R P ) ,  c h r o m o g e n 
3,3’,5,5’-tetramethylbenzidine (TMB) is oxidised to a 
coloured cation. In the second reaction, this coloured cation 
is reduced by antioxidants to a colourless compound.
Standard solution was prepared by mixing different 
proportions (0–100 %) of 1 mmol/L H2O2 with 6 mmol/L 
uric acid in 10 mmol/L NaOH. To prepare solution of TMB 
cation, a mixture of 0.1 mL TMB/DMSO (6 mg/mL), 5 mL 
acetate buffer (0.05 mmol/L, pH 4.5) and 17.5 µL freshly 
made chloramine T (100 mmol/L), was mixed, shacked for 
1 h at 37 ºC, and incubated in a dark place. Then 2.5 U of 
enzyme solution HRP was added to this mixture. TMB 
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noticeable (59.54 % for 2 mg/mL, 72 h treatment, p<0.001). 
Cell viability decreases with increasing YGRE concentration, 
at both exposure times. Statistically significant reduction 
was observed for concentrations of 1 and 2 mg/mL for both 
48 (p<0.05 and p<0.01, respectively) and 72 h treatment 
(p<0.01 and p<0.001, respectively, Figure 3a).
Incidence of chromosome aberrations
The results of chromosome aberrations assay showed 
that incidence of chromosomal breaks increased with the 
increase of YGRE concentration after 48 h of treatment, 
from 0.8 % (0.5 mg/mL) to 8.11 % (2 mg/mL) (Figure 3 
b). Chromosome aberrations were also analysed after 72 h 
to evaluate the impact of prolonged incubation on DNA 
damage repair. The trend of increasing frequency of breaks 
was noticed after 72 h treatment for concentrations of 1 and 
2 mg/mL (0.93 and 5.1 %, respectively), however the 
percentage of breaks was reduced comparing to 48 h 
treatment (Figure 3). The concentration of 0.5 mg/mL did 
not induce chromosomal breaks after 72 h. Figure 4 shows 
the appearance radial figures between homologous 
chromosomes at 2 mg/mL of YGRE, which are indicators 
of double-strand break (DSB) repair.
As expected, the percentage of chromosome breaks 
inversely correlated with viability assay for both treatment 
times (p<0.01, r=-0.67 for 48 h treatment and p<0.01, 
r=-0.89 for 72 h treatment).
Comet assay
All tested YGRE concentrations increased the 
percentage of DNA in the comet tail compared to control 
after 48 h of treatment and the difference was significant 
for the two higher concentrations (p<0.001) (Figure 5). 
Again, as expected, the parameter percentage of DNA in 
the comet tail inversely correlated with cell viability 
(p<0.01, r=-0.797).
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RESULTS
Characterisation of yellow gentian root extract (YGRE) 
particle sizes by Field Emission Scanning Electron 
Microscopy (FESEM) with energy dispersive 
spectroscopy (EDS)
Analysis of FESEM photomicrograph showed that the 
particle size in dispersed root powder was 53.9±2.95 µm 
(Figure 1 a). After filtration and lyophilisation, the particles 
displayed laminar or plate-like structure: smaller particles 
formed aggregates, whose average dimension was 
68.4±3.6 µm (Figure 1 b). The aggregates were mostly 
composed of soluble compounds, since particles observed 
in the lyophilisate dissolved in 50 % ethanol (concentration 
of 50 mg/mL) were of a much smaller dimension – 
15.8±1.3 µm (Figure 1 c).
Ultra performance liquid chromatography (UPLC) with 
PDA detector
Analytical standards of selected compounds were used 
to identify some of the most intensive peaks in chromatogram. 
Detailed data are presented in the report by Valenta Šobot 
et al. (24). Figure 2 shows UPLC chromatograms of YGRE 
ethanolic solution exported from 3D chromatograms at three 
wavelengths, revealing a high content of gentiopicroside 
and high stability of other compounds during treatment.
Cell viability
Figure 3a shows results of cell viability assay. All 
treatments reduced cell viability to a certain extent ranging 
from mild (91.84 % for 0.5 mg/mL, 48 h treatment) to more 
Figure 1 Particle size distribution of dispersed particles in (a) 
yellow gentian root powder; (b) lyophilisate; and (c) dissolved 
lyophilisate (pre-filtrate). Scale bar – 100 µm
Figure 2 UPLC chromatograms of yellow gentian root extract in 
ethanol solution exported at 254 nm (a); 300 nm (b); 270 nm (c); 
and 240 nm (d). 1 – loganic acid; 2 – swertiamarin; 3 – overlapping 
gentiopicroside and sweroside peaks
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Oxidative stress
The levels of PAB and LPP were the highest (67.9 
arbitrary HK units and 1.79 nmol/mg of proteins, 
respectively) and statistically significant for the lowest 
concentration of 0.5 mg/mL (p<0.001), while they dropped 
toward control levels at higher concentrations (Figure 6). 
PAB and LPP positively correlated (p<0.01, r=0.894).
DISCUSSION
Our results demonstrate concentration- and time-
dependent reduction in survival of PBMC after exposure 
to increasing concentrations of YGRE. Similar results were 
reported after treatment of human lymphocytes with extracts 
from other plants of the Gentianaceae family, which have 
similar constituents, such as Gentiana asclepiadea and 
Gentiana kurroo Royle (25, 26). Concentration-dependent 
cytotoxic effects of YGRE were, likewise, observed in 
cancer cell lines, such as cervical, breast, prostate and colon 
cancer (14, 15). However, cytotoxic outcomes in those 
studies were observed at lower concentrations, most likely 
due to differences in the metabolism of cancer cells and 
terminally differentiated peripheral blood T-lymphocytes. 
Different response to yellow gentian between malignant 
and healthy tissue was already observed in a study of its 
radioprotective effects (7).
In view of the contradictory literature data about the 
effects of yellow gentian, we wanted to see whether its 
cytotoxicity was associated with redox parameters and DNA 
damage, and found that only the lowest YGRE concentration 
increased redox parameters, which, however, led to only a 
minor DNA damage and mild cytotoxicity. Over the decades 
many studies focused on the relationship between oxidative 
stress and DNA damage, evidencing strong interplay 
between reactive oxygen species (ROS) production and 
DNA alterations that trigger genomic instability and cell 
death (27, 28). Our results indicate that pro-oxidant state 
and elevated lipid peroxidation products observed after 
treatment with the lowest YGRE concentration did not lead 
to significant DNA damage. In contrast, higher extract 
concentrations only slightly reduced PAB and LPP levels, 
but provoked significant DNA damage seen as an increased 
percentage of DNA in the comet tail and frequency of 
chromosomal aberrations. This may be due to the capacity 
Figure 3 Cell viability expressed as percentage of control (a) and percentage of chromosome breaks (b) at different concentrations of 
yellow gentian root extract after 48 and 72 h treatment. *p<0.05, **p<0.01, ***p<0.001
Figure 4 Photomicrograph of metaphase spreads after 72 h treatment with 2 mg/mL of yellow gentian root extract. Arrows mark 
chromatid break (a) and radial figure between two homologous chromosomes (17q) an indicator of homologous recombination - a 
mechanism of template-dependent DNA DSBs repair (b)
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of antioxidative defence, which is triggered only after a 
critical concentration of the tested compound is reached.
A comprehensive study by Kusar et al. (29) showed that 
YGRE displays strong antioxidative features by scavenging 
DPPH (2,2-diphenyl-1-picrylhydrazyl) and superoxide 
radical, but only at high concentrations of 19.0 mg/mL and 
11.1 mg/mL. Similar findings were reported by several 
studies, but all of them were obtained in ex vivo experiments 
(4, 14, 30). The reported scavenging effect was probably 
due to the higher amount of constituents with antioxidant 
capacity, namely flavonoids, xanthones, and secoiridoids 
(31). Others (32, 33) demonstrated in vivo concentration-
dependent antioxidative activity of G. cruciata and G. 
asclepiadea extracts rich in secoiridoids swertiamarin, 
sweroside, and gentiopicrin.
On the other hand, lower extract concentrations may 
favour pro-oxidant effects of other constituents, which leads 
to increased lipid peroxidation. The balance between extract 
constituents and their individual effects was well illustrated 
by Petrovic et al. (34), who found that a G. dinarica extract 
decreased lipid peroxidation products in peripheral blood 
lymphocytes, even though treatment with the same 
concentration of individual polyphenol compounds found 
in this plant generated opposite results. Isoorientin, 
isoorientin-4′-O-glycoside and norswertianin-1-O-
primveroside had antioxidative, while norswertianin-8-O-
primveroside and gentiacaulein displayed pro-oxidative 
effects. These results suggest that the cumulative outcome 
of plant extract mostly depends on the balance between its 
constituents and their individual pro-oxidative or 
antioxidative effects.
However, since higher extract concentrations induced 
significant DNA damage and reduced cellular survival, it 
is more likely that increasing YGRE concentrations provoke 
higher production of ROS, which consequently activate 
antioxidant enzymes such as SOD and catalase and 
endogenous antioxidant glutathione (GSH). Once activated, 
they could prevent oxidative damage within the cells to a 
certain extent, while a portion of cells is damaged beyond 
the repair capacity of terminally differentiated cells, as 
evidenced by diminished cell viability, and higher DNA 
damage. Treatment with 2 mg/mL of YGRE reduced cellular 
viability to 78.57 %, led to a significant increase of DNA % 
in the comet tail (from 6.41 to 32.98 %) and produced 
8.11 % of chromosomal breaks after the 48-hour treatment, 
whereas PAB and LPP levels dropped to nearly control 
values. With longer exposure (72 h) cytotoxicity was even 
more pronounced, as cell viability decreased to 59.54 %.
Other research groups also reported genotoxic and 
cytotoxic effects of different concentrations of Gentiana 
extracts. For instance, G. asclepiadea root extract increased 
comet tail length in rats treated with 400 mg/kg of body 
weight and dose-dependently increased comet tail intensity 
in human peripheral blood lymphocytes (26, 33). G. 
Figure 5 Graph (a) and photomicrograph (b-e) of YGRE-induced DNA damage established with the comet assay. b – control; c – 
0.5 mg/mL; d – 1 mg/mL; e – 2 mg/mL; YGRE – yellow gentian root extract. Scale bar – 10 µm. ***p<0.001
Figure 6 PAB levels presented as arbitrary HK units (a) and LPP levels expressed as nmol/mg of proteins (b) after treatment with 
increasing concentrations of yellow gentian root extract. ***p<0.001
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dinarica extract elevated the frequency of micronuclei and 
enhanced apoptosis in peripheral blood lymphocytes (34). 
Similar results were found for many plant extracts known 
for their antioxidant activity and rich in polyphenols, such 
as black and green tea extract, suggesting that higher 
polyphenol concentrations could lead to spontaneous H2O2 
generation, DNA damage, and cell death (35, 36). In line 
with this argument, the concentration determines whether 
certain compound or extract acts as anti- or pro-oxidant.
Interestingly, in our study the frequency of chromosomal 
breaks was lower after 72 h of treatment for all tested 
concentrations. These and cell viability findings suggest 
that DNA repair mechanisms are activated in cells with 
aberrations that could be fixed, while the cells damaged 
beyond repair die. This is well illustrated by radial figures 
observed after 72 h of YGRE treatment, as they indicate 
homologous recombination, an important template-
dependent DNA repair mechanism, specific for repair of 
double-strand breaks (DSBs). This is in accordance with 
the report by Patenković et al. (12), who demonstrated 
homologous mitotic recombination in Drosophila treated 
with YGRE (12). Even though homologous recombination 
could have negative effect due to loss of heterozygosity, 
activation of this repair mechanism is vital for the recovery 
from oxidative DNA damage (12, 37, 38). Upon oxidative 
DNA damage, complex protein network activates, including 
ATM, ATR, RAD50 and MRE11A proteins, leading to 
upregulation of RAD50, RAD51, XRCC2 and XRCC3 gene 
and protein levels, which contribute to the survival of 
affected cells (28, 37, 38).
CONCLUSION
The results of our study suggest that, although YGRE 
displayed concentration- and time-dependent cytotoxic and 
genotoxic effects, it activates repair mechanisms that 
counter oxidative and DNA lesions and induces cell death 
in cells damaged beyond repair. DNA fragmentation could 
serve to predict the cytotoxic effects of yellow gentian, as 
increased fragmentation was observed 24 h before 
significant increase in cell death. Considering these findings, 
it appears that the protective effects of yellow gentian result 
from the activation of cell defences and death of the cells 
beyond repair. However, since there is a clear correlation 
between concentration, treatment duration and toxic effects, 
and that these effects were observed at cell level, further 
studies are needed to get a better insight into the cyto/
genoprotective potential of YGRE, and this compound 
should be used with caution.
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Učinak ekstrakta korijena žute lincure na mononuklearne stanice periferne krvi ovisi o njegovoj koncentraciji i 
vremenu izlaganja
Žuta lincura (Gentiana lutea L.), ljekovita biljka koja se često koristi u tradicionalnoj medicini, pokazuje višestruke 
biološke učinke, od korisnih do toksičnih. Budući da je do sada zabilježeno mnogo mogućih primjena, cilj nam je bio 
procijeniti potencijalne citotoksične i genotoksične učinke ekstrakta korijena te biljke, koji ovise o njegovoj koncentraciji 
i vremenu izlaganja in vitro. Mononuklearne stanice ljudske periferne krvi izložili smo ekstraktu korijena žute lincure 
(YGRE), koncentracije 0,5 mg/mL, 1 mg/mL i 2 mg/mL, da bismo utvrdili njegove učinke na parametre oksidacijskoga 
stresa [pro/antioksidacijski balans (PAB) i peroksidacija lipida], oštećenja DNA (alkalni komet test i kromosomske 
aberacije) i preživljavanje stanica (tripan plavo bojenje). Preživljavanje stanica smanjivalo se s povećanjem koncentracije 
i trajanja izlaganja. Samo najniža koncentracija YGRE-a (0,5 mg/mL) dovela je do povećanja oksidacijskoga stresa, ali 
je proizvela manja oštećenja DNA i citotoksičnost. Pri višim koncentracijama, redoks parametri vratili su se blizu razine 
kontrolnih vrijednosti. Postotak kromosomskih aberacija i postotak DNA u repu kometa povećavao se s povećanom 
koncentracijom YGRE-a nakon 48 sati i smanjivao nakon 72 sata tretmana. To upućuje na aktiviranje mehanizma popravka 
DNA (homologna rekombinacija), što dokazuje prisutnost kromosomskih radijalnih struktura nakon 72 sata tretmana 
najvišom koncentracijom YGRE-a od 2 mg/mL. Naši rezultati pokazuju da YGRE, unatoč induciranju citotoksičnih i 
genotoksičnih učinaka, aktivira mehanizme popravka stanica koji suzbijaju oksidacijske i DNA lezije i induciraju smrt 
visoko oštećenih stanica. Zaključak je da uočeni zaštitni učinci dužeg izlaganja ekstraktu korijena žute lincure mogu biti 
rezultat aktivnoga popravka i uklanjanja stanica s nepopravljivim oštećenjima.
KLJUČNE RIJEČI: citotoksičnost; genotoksičnost; Gentiana lutea L.; homologna rekombinacija; redoks parametri
